Paul Jellinger, MD, MACE, from the Center for Diabetes and Endocrine Care, explains the answer to the quiz question from part 1 of the series, talks about the AACE lipid guidelines, and the role of renal disease in managing this patient.
Additional Resources:
ASCVD RISK CATEGORIES AND LDL-C TREATMENT GOALS
AACE/ACE GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION
OF CARDIOVASCULAR DISEASE
PODCAST: AACE/ACE GUIDELINES: THE LOWER THE LDL, THE BETTER
Paul S. Jellinger, MD, MACE, is a professor of clinical medicine on the voluntary faculty at the University of Miami Miller School of Medicine and is in private practice at the Center for Diabetes and Endocrine Care in Hollywood, Florida. He is also the Past President of the American Association of Clinical Endocrinologists (AACE) and Past President of the American College of Endocrinology.
